Molecular link traced from gene to late-onset retinal degeneration

Clinical trial planning underway to test the widely used diabetes drug metformin as a preventive treatment for the blinding eye disease. Scientists have discovered that gene therapy and the diabetes drug metformin may be potential treatments for late-onset retinal degeneration (L-ORD), a rare, blinding eye disease. Researchers from the National Eye Institute (NEI), part of the National Institutes of Health […]

Stem cell therapy as potential glaucoma treatment

Oregon Health & Science University is part of a national research project investigating stem cell therapy as a potential treatment for glaucoma, the world’s second leading cause of blindness. With support from the National Institutes of Health, the project is studying human stem cells that are made into retinal ganglion cells, neurons involved in sight that are damaged by glaucoma. The research […]